SPDR S&P Pharmaceuticals ETF Rating → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free XPH Stock Alerts $40.43 +0.31 (+0.77%) (As of 05/31/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy2.65Holdings in XPH have an aggregate rating of Moderate Buy based on 298 analyst ratings issued in the past year covering 40 companies (98.7% of the portfolio).XPH Aggregate Price Target$66.6164.76% UpsideHigh Prediction$86.03Average Prediction$66.61Low Prediction$47.36Holdings in XPH have an aggregate price target of $66.61 and a range of $47.36 to $86.03 covering 40 companies (98.7% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 XPH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.51%OGNOrganon & Co.$21.33+1.9%5 of 5 stars2.50$22.60 6.0%4Short Interest ↓5.02%PFEPfizer$28.66+1.6%5 of 5 stars2.40$35.86 25.1%15High Trading Volume5.01%MRKMerck & Co., Inc.$125.54+0.8%4 of 5 stars2.58$131.33 4.6%12Dividend AnnouncementHigh Trading Volume4.94%AXSMAxsome Therapeutics$73.43-1.1%5 of 5 stars2.92$121.92 66.0%13Insider Selling4.88%ELANElanco Animal Health$17.68+0.5%2 of 5 stars2.57$18.29 3.4%7Short Interest ↑4.78%LLYEli Lilly and Company$820.34+0.6%5 of 5 stars2.84$769.53 -6.2%19Insider Selling4.66%ITCIIntra-Cellular Therapies$67.24+2.4%4 of 5 stars2.90$90.17 34.1%10Short Interest ↑4.63%PRGOPerrigo$27.53+0.8%5 of 5 stars3.00$40.67 47.7%3Analyst UpgradeShort Interest ↑Analyst RevisionNews Coverage4.62%CTLTCatalent$53.79+0.3%3 of 5 stars2.17$53.14 -1.2%12Analyst ForecastHigh Trading Volume4.57%JNJJohnson & Johnson$146.67+1.0%5 of 5 stars2.38$174.07 18.7%13Analyst ForecastHigh Trading Volume4.50%ZTSZoetis$169.56+0.1%5 of 5 stars3.00$211.75 24.9%7Short Interest ↑4.44%JAZZJazz Pharmaceuticals$105.25-0.2%5 of 5 stars2.85$192.75 83.1%13Analyst UpgradeHigh Trading Volume4.34%RPRXRoyalty Pharma$27.41+3.9%5 of 5 stars3.00$46.75 70.6%4Positive NewsHigh Trading Volume4.25%VTRSViatris$10.60+1.1%1 of 5 stars1.33$11.00 3.8%3Insider Selling3.99%CORTCorcept Therapeutics$30.17-3.3%5 of 5 stars3.00$40.10 32.9%4Analyst ForecastInsider SellingAnalyst RevisionNews CoveragePositive NewsGap Up3.87%BMYBristol-Myers Squibb$41.09+2.1%5 of 5 stars2.11$60.00 46.0%19High Trading Volume2.42%ARVNArvinas$33.14+2.8%3 of 5 stars2.88$61.13 84.5%16Positive News2.16%AMPHAmphastar Pharmaceuticals$42.33+0.4%5 of 5 stars2.50$66.00 55.9%4Short Interest ↓Positive News2.00%SAVACassava Sciences$22.03-1.9%3 of 5 stars3.00$131.00 494.6%1Positive News1.96%TARSTarsus Pharmaceuticals$32.96-5.1%2 of 5 stars2.88$50.38 52.8%8Positive News1.44%PCRXPacira BioSciences$30.33-0.4%5 of 5 stars3.00$47.40 56.3%10Short Interest ↑Analyst RevisionPositive News1.41%EYPTEyePoint Pharmaceuticals$10.71-0.4%2 of 5 stars3.00$33.71 214.8%7Short Interest ↑1.30%PBHPrestige Consumer Healthcare$64.31+2.4%5 of 5 stars2.50$91.25 41.9%4Positive News1.22%LBPHLongboard Pharmaceuticals$18.87+5.4%1 of 5 stars3.00$43.67 131.4%6News CoveragePositive NewsHigh Trading Volume1.13%HRMYHarmony Biosciences$29.40+1.8%4 of 5 stars2.50$40.63 38.2%8Short Interest ↑1.02%COLLCollegium Pharmaceutical$33.14+2.2%3 of 5 stars2.20$39.00 17.7%5Insider Selling0.97%LQDALiquidia$12.87+0.1%3 of 5 stars2.60$21.00 63.2%5Positive NewsHigh Trading Volume0.95%AMRXAmneal Pharmaceuticals$6.68-1.5%2 of 5 stars3.00$8.25 23.5%4Short Interest ↑0.94%LGNDLigand Pharmaceuticals$85.05+1.3%5 of 5 stars3.00$116.33 36.8%3Positive News0.91%AMLXAmylyx Pharmaceuticals$1.72+2.4%4 of 5 stars2.25$28.67 1,566.7%8Short Interest ↓Positive News0.85%SUPNSupernus Pharmaceuticals$27.12+2.1%4 of 5 stars3.00$41.00 51.2%1Positive News0.73%PLRXPliant Therapeutics$12.13-0.3%4 of 5 stars3.00$45.38 274.1%9Positive News0.60%ANIPANI Pharmaceuticals$64.90+2.3%5 of 5 stars3.00$81.00 24.8%4Short Interest ↓Positive News0.53%EOLSEvolus$12.93+2.5%4 of 5 stars3.00$21.25 64.3%3Positive News0.51%RVNCRevance Therapeutics$2.84-1.7%4 of 5 stars2.50$11.50 304.9%80.45%OCULOcular Therapeutix$5.70-1.7%4 of 5 stars2.83$15.17 166.1%6Analyst ForecastPositive NewsGap Up0.40%XERSXeris Biopharma$2.26+1.3%4 of 5 stars3.00$4.63 105.1%4Analyst ForecastHigh Trading Volume0.39%TBPHTheravance Biopharma$8.62+1.5%2 of 5 stars3.00$20.50 137.8%2Analyst DowngradeAnalyst Revision0.29%FULCFulcrum Therapeutics$7.85+2.6%3 of 5 stars3.00$15.57 98.4%7Positive News0.06%MRNSMarinus Pharmaceuticals$1.42-2.7%4 of 5 stars2.57$13.79 870.8%7Gap Down This page (NYSEARCA:XPH) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
